Cargando…

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry

Understanding the mechanism for antibody neutralization of SARS-CoV-2 is critical for the development of effective therapeutics and vaccines. We recently isolated a large number of monoclonal antibodies from SARS-CoV-2 infected individuals. Here we select the top three most potent yet variable neutr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ge, Jiwan, Wang, Ruoke, Ju, Bin, Zhang, Qi, Sun, Jing, Chen, Peng, Zhang, Senyan, Tian, Yuling, Shan, Sisi, Cheng, Lin, Zhou, Bing, Song, Shuo, Zhao, Juanjuan, Wang, Haiyan, Shi, Xuanling, Ding, Qiang, Liu, Lei, Zhao, Jincun, Zhang, Zheng, Wang, Xinquan, Zhang, Linqi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801515/ https://www.ncbi.nlm.nih.gov/pubmed/33431856 http://dx.doi.org/10.1038/s41467-020-20501-9

Ejemplares similares

Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species
por: Wang, Ruoke, et al.
Publicado: (2021)

Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2
por: Zhang, Qi, et al.
Publicado: (2021)

Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses
por: Li, Mingxi, et al.
Publicado: (2022)

SARS-CoV-2 Omicron Variants Reduce Antibody Neutralization and Acquire Usage of Mouse ACE2
por: Wang, Ruoke, et al.
Publicado: (2022)

Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants
por: Ju, Bin, et al.
Publicado: (2023)

Antibodies and vaccines against Middle East respiratory syndrome coronavirus
por: Xu, Jiuyang, et al.
Publicado: (2019)

A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants
por: Shan, Sisi, et al.
Publicado: (2021)

Structural insights into the binding of SARS-CoV-2, SARS-CoV, and hCoV-NL63 spike receptor-binding domain to horse ACE2
por: Lan, Jun, et al.
Publicado: (2022)

Structural Definition of a Unique Neutralization Epitope on the Receptor-Binding Domain of MERS-CoV Spike Glycoprotein
por: Zhang, Senyan, et al.
Publicado: (2018)

Structural insights into the SARS-CoV-2 Omicron RBD-ACE2 interaction
por: Lan, Jun, et al.
Publicado: (2022)

Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2
por: Ji, Yun, et al.
Publicado: (2022)

Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies
por: Yan, Renhong, et al.
Publicado: (2021)

A Single Injection of Human Neutralizing Antibody Protects against Zika Virus Infection and Microcephaly in Developing Mouse Embryos
por: Li, Cui, et al.
Publicado: (2018)

Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry
por: Park, Young-Jun, et al.
Publicado: (2021)

Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry
por: Park, Young-Jun, et al.
Publicado: (2022)

Single intranasal immunization with chimpanzee adenovirus-based vaccine induces sustained and protective immunity against MERS-CoV infection
por: Jia, Wenxu, et al.
Publicado: (2019)

Structural basis for the neutralization of MERS-CoV by a human monoclonal antibody MERS-27
por: Yu, Xiaojuan, et al.
Publicado: (2015)

Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein
por: Zhou, Haixia, et al.
Publicado: (2019)

RBD trimer mRNA vaccine elicits broad and protective immune responses against SARS-CoV-2 variants
por: Liang, Qingtai, et al.
Publicado: (2022)

Establishment of replication-competent vesicular stomatitis virus-based recombinant viruses suitable for SARS-CoV-2 entry and neutralization assays
por: Li, Hongyue, et al.
Publicado: (2020)

Potent neutralizing monoclonal antibodies against Ebola virus infection
por: Zhang, Qi, et al.
Publicado: (2016)

Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
por: Wang, Nianshuang, et al.
Publicado: (2013)

Development of a Potent and Protective Germline-Like Antibody Lineage Against Zika Virus in a Convalescent Human
por: Gao, Fei, et al.
Publicado: (2019)

Deep learning guided optimization of human antibody against SARS-CoV-2 variants with broad neutralization
por: Shan, Sisi, et al.
Publicado: (2022)

A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus
por: Zhu, Qian-Ying, et al.
Publicado: (2021)

Optimized ACE2 decoys neutralize antibody-resistant SARS-CoV-2 variants through functional receptor mimicry and treat infection in vivo
por: Torchia, James A., et al.
Publicado: (2022)

Structural basis of a two-antibody cocktail exhibiting highly potent and broadly neutralizing activities against SARS-CoV-2 variants including diverse Omicron sublineages
por: Li, Xiaoman, et al.
Publicado: (2022)

The spike glycoprotein of highly pathogenic human coronaviruses: structural insights for understanding infection, evolution and inhibition
por: Qiao, Shuyuan, et al.
Publicado: (2022)

Cryoelectron microscopy structures of a human neutralizing antibody bound to MERS-CoV spike glycoprotein
por: Zhang, Shuyuan, et al.
Publicado: (2022)

LOXL2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma
por: Shao, Bing, et al.
Publicado: (2018)

Bat and pangolin coronavirus spike glycoprotein structures provide insights into SARS-CoV-2 evolution
por: Zhang, Shuyuan, et al.
Publicado: (2021)

ACE2 decoy receptor generated by high-throughput saturation mutagenesis efficiently neutralizes SARS-CoV-2 and its prevalent variants
por: Wang, Bolun, et al.
Publicado: (2022)

Immune responses to SARS-CoV-2 infection in Humans and ACE2 humanized mice
por: Zhu, Airu, et al.
Publicado: (2021)

Repurposing CRISPR/Cas to Discover SARS‐CoV‐2 Detecting and Neutralizing Aptamers
por: Zhang, Ju, et al.
Publicado: (2023)

Increased resistance of SARS-CoV-2 Lambda variant to antibody neutralization
por: Guo, Huimin, et al.
Publicado: (2022)

SARS-CoV-2 induces cardiomyocyte apoptosis and inflammation but can be ameliorated by ACE inhibitor Captopril
por: Huang, Xiaohan, et al.
Publicado: (2023)

Broadly resistant HIV-1 against CD4-binding site neutralizing antibodies
por: Zhou, Panpan, et al.
Publicado: (2019)

Sialylated immunoglobulin G can neutralize influenza virus infection through receptor mimicry
por: Huang, Tao, et al.
Publicado: (2016)

A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants
por: Du, Yanyun, et al.
Publicado: (2021)

Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies
por: Cheng, Lin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eqtcks78ucsgurrcdgji3kkii3